This page contains a Flash digital edition of a book.
Technology and product review Biatain® Silicone dressings: A case series evaluation


In the third case, adverse events (described as rise of exudate, erythema, and rise of pain) were considered related to the dressing.


DISCUSSION In this study, a total of 39 patients were treated with Biatain Silicone or Biatain Silicone Lite for two weeks or six dressing changes. To evaluate these products, patients and HCPs were given questionnaires to determine their experiences with the products. Overall, all the HCPs felt that these products performed better than previously used dressings [Figure 9] and that they would use them again. The majority of the patients (87%) considered the product to be very comfortable or comfortable to wear, and only one rated it as uncomfortable. The HCP also rated the dressing worse than the previous dressing on this particular patient. The patient was a 75-year-old lady who had a mixed arterial/venous leg ulcer and was dressed with a Biatain Silicone Lite dressing. On consideration, the standard Biatain Silicone dressing might have been a better choice as it is better suited for moderate- to high-exuding wounds. Overall, the HCPs rated the Biatain Silicone


dressings better than previously used products. From the case study findings, the authors conclude that these dressings offer patients a comfortable treatment option with optimal exudate management for all evaluated wound types. In addition, they were very easy to apply and remove and stayed in place during wear.


CASE REPORTS The study evaluated the usability of the Biatain Silicone products; questions on clinical parameters such as wound progress and changes in condition of periwound skin were not included in the questionnaire. However, as photos were taken, we have included three case study examples using data included in the participants’ healthcare records, and these are described below.


Case study 1 – donor site wound This was a 66-year-old woman with a high-exuding donor site [Figure 10A]. After grafting, Biatain Silicone dressing was applied [Figure 10B]. The dressing showed very good absorption of exudate [Figure 10C]; this was worn for three days (mean wear time was 3.75 days). All dressing changes were routine and pain free. The dressing was easy to remove and did not leave any fibres in the wound bed. After two weeks of treatment the wound was improved with evidence of 30% granulation


Figure 10. Case study 1 – donor site wound. [A] Donor site at baseline, [B] after application of Biatain® Silicone, [C] dressing after 3 days wear and [D] donor site after 2 weeks of treatment.


[A] [B]


[C]


[D]


tissue and 70% epithelialisation [Figure 10D]. The dressing was very easy to apply, conformed well to the wound bed and stayed in place during wear time. The patient found the dressing very comfortable.


Case study 2 – diabetic foot ulcer This was a 45-year-old man with a moderately exuding diabetic foot ulcer [Figure 11A]. The duration of the ulcer was six months and the periwound skin was fragile with signs of skin


[A] [B]


[C]


[D]


Figure 11. Case study 2 – diabetic foot ulcer (DFU). {A] DFU at baseline, [B] Biatain® Silicone Lite dressing in situ, [C] dressing on removal, [D] DFU after 2 weeks of treatment.


Wounds International Vol 5 | Issue 1 | ©Wounds International 2014 | www.woundsinternational.com 23


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30